2/26
08:22 am
kymr
Form 8-K Kymera Therapeutics, For: Feb 26
Medium
Report
Form 8-K Kymera Therapeutics, For: Feb 26
2/26
08:18 am
kymr
Form 424B3 Kymera Therapeutics,
Medium
Report
Form 424B3 Kymera Therapeutics,
2/26
08:15 am
kymr
Form 424B5 Kymera Therapeutics,
Medium
Report
Form 424B5 Kymera Therapeutics,
2/26
07:34 am
kymr
Form S-8 Kymera Therapeutics,
Low
Report
Form S-8 Kymera Therapeutics,
2/26
07:16 am
kymr
Form 10-K Kymera Therapeutics, For: Dec 31
Low
Report
Form 10-K Kymera Therapeutics, For: Dec 31
2/26
07:10 am
kymr
Form 8-K Kymera Therapeutics, For: Feb 26
Low
Report
Form 8-K Kymera Therapeutics, For: Feb 26
2/25
05:24 pm
kymr
Form 4 Kymera Therapeutics, For: Feb 25 Filed by: Mainolfi Nello
Medium
Report
Form 4 Kymera Therapeutics, For: Feb 25 Filed by: Mainolfi Nello
2/25
04:03 pm
kymr
Form 144 Kymera Therapeutics, Filed by: Mainolfi Nello
Low
Report
Form 144 Kymera Therapeutics, Filed by: Mainolfi Nello
2/20
05:30 pm
kymr
Form 4 Kymera Therapeutics, For: Feb 20 Filed by: Esposito Pamela
Low
Report
Form 4 Kymera Therapeutics, For: Feb 20 Filed by: Esposito Pamela
2/20
04:28 pm
kymr
Form 144 Kymera Therapeutics, Filed by: Esposito Pamela
Low
Report
Form 144 Kymera Therapeutics, Filed by: Esposito Pamela
2/10
11:18 am
kymr
Form SCHEDULE 13G/A Kymera Therapeutics, Filed by: WELLINGTON MANAGEMENT GROUP LLP
Low
Report
Form SCHEDULE 13G/A Kymera Therapeutics, Filed by: WELLINGTON MANAGEMENT GROUP LLP
1/20
06:30 pm
kymr
Form 4 Kymera Therapeutics, For: Jan 20 Filed by: Esposito Pamela
Medium
Report
Form 4 Kymera Therapeutics, For: Jan 20 Filed by: Esposito Pamela
1/20
04:29 pm
kymr
Form 144 Kymera Therapeutics, Filed by: Esposito Pamela
Medium
Report
Form 144 Kymera Therapeutics, Filed by: Esposito Pamela
1/13
07:08 am
kymr
Form 8-K Kymera Therapeutics, For: Jan 13
Medium
Report
Form 8-K Kymera Therapeutics, For: Jan 13
1/8
09:10 am
kymr
Form SCHEDULE 13G/A Kymera Therapeutics, Filed by: FMR LLC
Low
Report
Form SCHEDULE 13G/A Kymera Therapeutics, Filed by: FMR LLC
1/6
04:40 pm
kymr
Form 4 Kymera Therapeutics, For: Jan 05 Filed by: Mainolfi Nello
Medium
Report
Form 4 Kymera Therapeutics, For: Jan 05 Filed by: Mainolfi Nello
12/31
05:24 pm
kymr
Form 4 Kymera Therapeutics, For: Dec 31 Filed by: Mainolfi Nello
Medium
Report
Form 4 Kymera Therapeutics, For: Dec 31 Filed by: Mainolfi Nello
12/31
04:06 pm
kymr
Form 144 Kymera Therapeutics, Filed by: Mainolfi Nello
Medium
Report
Form 144 Kymera Therapeutics, Filed by: Mainolfi Nello
12/17
06:08 pm
kymr
Form 4 Kymera Therapeutics, For: Dec 17 Filed by: Mainolfi Nello
Low
Report
Form 4 Kymera Therapeutics, For: Dec 17 Filed by: Mainolfi Nello
12/17
06:07 pm
kymr
Form 4 Kymera Therapeutics, For: Dec 17 Filed by: Esposito Pamela
Low
Report
Form 4 Kymera Therapeutics, For: Dec 17 Filed by: Esposito Pamela
12/17
04:24 pm
kymr
Form 144 Kymera Therapeutics, Filed by: Esposito Pamela
Low
Report
Form 144 Kymera Therapeutics, Filed by: Esposito Pamela
12/15
06:08 pm
kymr
Form SCHEDULE 13D/A Kymera Therapeutics, Filed by: BIOTECHNOLOGY VALUE FUND L P
Low
Report
Form SCHEDULE 13D/A Kymera Therapeutics, Filed by: BIOTECHNOLOGY VALUE FUND L P
12/12
06:37 pm
kymr
Form 4 Kymera Therapeutics, For: Dec 10 Filed by: Booth Bruce
Medium
Report
Form 4 Kymera Therapeutics, For: Dec 10 Filed by: Booth Bruce
12/12
05:20 pm
kymr
Form 144 Kymera Therapeutics, Filed by: Atlas Venture Opportunity Fund I, L.P.
Medium
Report
Form 144 Kymera Therapeutics, Filed by: Atlas Venture Opportunity Fund I, L.P.
12/12
05:09 pm
kymr
Form 144 Kymera Therapeutics, Filed by: Atlas Venture Fund X, L.P.
Medium
Report
Form 144 Kymera Therapeutics, Filed by: Atlas Venture Fund X, L.P.